CTI Biopharma Corp.

549300RJTND7CT8R8853

The entity

Country: United States
Legal address: C/O CT Corporation System, 505 Union Avenue South East, Suite 12098501 OlympiaUnited States (US-WA)
Head office: 3101 Western Avenue, Suite 60098121 SeattleUnited States (US-WA)

LEI: 549300RJTND7CT8R8853
Registered: November 8, 2014 at 01:41 AM UTC
Last updated: August 4, 2023 at 05:15 PM UTC
Next renewal: May 26, 2018 at 03:16 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Corporations Division (Office of the Secretary of State) (RA000641)
Identifier: 601339038
Verified against: Corporations Division (Office of the Secretary of State) (RA000641)
Verified as: 601339038
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

No direct parent reportedNo ultimate parent reported: The accounts are not published

REST: https://lei.online/v1/entities/549300RJTND7CT8R8853This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.